#5 - Amber Trivedi, COO at Blue Note Therapeutics

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Please try again later

Please try again later

Please try again later

Please try again

Please try again

Please try again

Listen for free

View show details

Welcome to DTx Equals, the show where thought-leaders in digital therapeutics put a stake in the ground about what makes DTx, DTx.

Our Guest Today: Amber Trivedi, COO at Blue Note Therapeutics

What you'll get out of this episode:

What is a formative event in your life or career that influenced your path into DTx?
DTx equals what? What is the most defining issue of DTx today?
How much of the problems with DTx getting reimbursment are around pricing? Do you think prices are being set too high, or do you think healthcare needs to readjust?
Are there places where healthcare can be disentangled from a human provider?
Where do you feel non-human DTx models really shine?
In your wildness dreams, what is something DTx will be able to do in the future that it can’t do today?

To learn more about Amber Trivedi and Blue Note Therapeutics please use the links below:

- Amber's LinkedIn - Blue Note Therapeutics LinkedIn - Blue Note Therapeutics Website

Also, be sure to follow DTx Equals on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

No reviews yet